Sunesis to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
* Reuters is not responsible for the content in this press release.
SOUTH SAN FRANCISCO, CA, Nov 12 (MARKET WIRE) --
Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) a biopharmaceutical company
focused on the development and commercialization of new oncology
therapeutics for the treatment of solid and hematologic cancers, today
announced that Daniel Swisher, Chief Executive Officer of Sunesis, will
be presenting at the Lazard Capital Markets Sixth Annual Healthcare
Conference on Wednesday, November 18, 2009 at 11:30 AM Eastern Time at
the St. Regis Hotel in New York City.
The live webcast of this presentation will be available on the Sunesis
website at http://ir.sunesis.com. A replay of the webcast will be archived
on the "Calendar of Events" page in the Investors and Media section of the
Sunesis website for two weeks.
About Sunesis Pharmaceuticals
Sunesis is a biopharmaceutical company focused on the development and
commercialization of new oncology therapeutics for the treatment of solid
and hematologic cancers. Sunesis has built a highly experienced cancer
drug development organization committed to advancing its lead product
candidate, voreloxin, in multiple indications to improve the lives of
people with cancer. For additional information on Sunesis, please visit
http://www.sunesis.com.
SUNESIS and the logo are trademarks of Sunesis Pharmaceuticals, Inc.
Investor and Media Inquiries:
Andrea Rabney
Argot Partners
212-600-1902
Eric Bjerkholt
Sunesis Pharmaceuticals Inc.
650-266-3717
Copyright 2009, Market Wire, All rights reserved.
-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters